Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons F. Zeevat

Publicaties

Cost-Effectiveness of Routine Infant Meningococcal B Vaccination in the Netherlands

Evaluating the cost-effectiveness of adjuvanted influenza vaccine in the older adult population in the Netherlands

The SENSS (Stress, Exercise, Nutrition, Sleep, Self-management) study: study protocol for a randomized controlled trial to evaluate an integrated, personalized and stepped care lifestyle approach for people with Parkinson’s disease

Use of Health State Utility Values in Cost-Utility Analyses of Selected Infectious Diseases in Aging Populations: A Systematic Review and Critical Appraisal

Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands

Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection

Evaluating cost-effectiveness of RSV vaccination strategies for older adults in the Netherlands

Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations

Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands: a Holistic Approach

Assessment of vaccination policies from a health economic perspective: opportunities and emerging foci

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 8 – Fatsoenlijk werk en economische groei

Meer informatie over de Sustainable Development Goals.